Clement Nicholas David, Duckworth Andrew David, MacKenzie Sam Peter, Nie Yuan Xin, Tiemessen Christopher Henricus
Department of Orthopaedics and Trauma, Borders General Hospital, Melrose, United Kingdom.
J Orthop Surg (Hong Kong). 2012 Aug;20(2):157-61. doi: 10.1177/230949901202000204.
To review medium-term results of 49 consecutive patients who underwent Oxford phase-3 medial unicompartmental knee arthroplasty by a single surgeon.
Records of 28 women (mean age, 71 years) and 21 men (mean age, 68 years) who underwent minimally invasive Oxford phase-3 medial unicompartmental knee arthroplasty by a single surgeon were retrospectively reviewed. The Oxford knee score and visual analogue scale (VAS) scores for pain and satisfaction were assessed at the latest follow-up by an independent observer, as were postoperative radiographs for implant position, osteoarthritic changes in the non-replaced compartments, and radiolucent lines of >2 mm or implant subsidence. The survival rate was calculated using Kaplan-Meier survival analysis. Patient demographics, postoperative alignment (varus/ valgus), Oxford knee scores, and the progression of osteoarthritis in the other compartments were included in a multiple logistic regression (MLR) analysis to identify significant factors affecting the probability of being satisfied (VAS scores for satisfaction of ≤2).
The mean follow-up duration was 7.2 years. No patient was lost to follow-up. Two patients with no knee symptoms died (unrelated to surgery) before the 5-year follow-up. The cumulative survival rate at the 9-year follow-up was 91.2% (95% confidence interval, 87.6-94.5%). There were 4 early failures (before 4 years). One patient early in the series developed avascular necrosis of the lateral femoral condyle with an over-corrected tibiofemoral valgus of 12º at 8 months; the other 3 complained of anterior knee pain, without signs of osteoarthritis. All 4 patients underwent revision with total knee arthroplasty. There were 43 patients with more than 5 years of follow-up and without revision of the prosthesis. Patients who were not satisfied (n=6) were more likely to be <65 years old (n=4, adjusted odds ratio [OR], 3.1; MLR p=0.002) and male (n=4; adjusted OR, 2.3; MLR p=0.02). Six of the 43 patients had lucent lines on radiographs, all of which were partial and under the tibial component. Progression of the arthritis in the patellofemoral and/or lateral compartments was worse in 5 patients.
Careful patient selection and good surgical technique contributed to good outcome. Younger male patients should be counselled regarding the higher chance of limited satisfaction.
回顾由单一外科医生实施牛津3期内侧单髁膝关节置换术的49例连续患者的中期结果。
回顾性分析28例女性(平均年龄71岁)和21例男性(平均年龄68岁)的记录,这些患者均由单一外科医生实施了微创牛津3期内侧单髁膝关节置换术。在最近一次随访时,由独立观察者评估牛津膝关节评分以及疼痛和满意度的视觉模拟量表(VAS)评分,同时评估术后X线片上的植入物位置、未置换关节间的骨关节炎变化以及大于2 mm的透亮线或植入物下沉情况。采用Kaplan-Meier生存分析计算生存率。患者人口统计学资料、术后对线情况(内翻/外翻)、牛津膝关节评分以及其他关节间骨关节炎的进展情况纳入多元逻辑回归(MLR)分析,以确定影响满意度(VAS满意度评分≤2)概率的显著因素。
平均随访时间为7.2年。无患者失访。2例无膝关节症状的患者在5年随访前死亡(与手术无关)。9年随访时的累积生存率为91.2%(95%置信区间,87.6 - 94.5%)。有4例早期失败(4年之前)。该系列早期有1例患者在8个月时出现外侧股骨髁缺血性坏死,胫股外翻矫正过度12°;另外3例主诉膝关节前方疼痛,无骨关节炎体征。所有4例患者均接受了全膝关节置换翻修手术。有43例患者随访超过5年且未进行假体翻修。不满意的患者(n = 6)更可能年龄小于65岁(n = 4,调整优势比[OR],3.1;MLR p = 0.002)且为男性(n = 4;调整OR,2.3;MLR p = 0.02)。43例患者中有6例X线片上出现透亮线,均为部分且位于胫骨组件下方。5例患者髌股关节和/或外侧关节间的关节炎进展更严重。
仔细的患者选择和良好的手术技术有助于取得良好的结果。对于年轻男性患者,应告知其满意度有限的可能性更高。